跳至主要内容
临床试验/PACTR202304665943139
PACTR202304665943139尚未招募Unknown

Efficacy and pregnancy outcome of oral metronidazole versus oral clindamycin for treating bacterial vaginosis in pregnancy at Ilorin, Nigeria. A randomized control trial.

self funded0 个研究点目标入组 500 人开始时间: 2023年4月9日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • All consenting pregnant women attending antenatal clinic at the study site between 20 and 26weeks of gestation.
  • Single live intrauterine foetus
  • Desire to deliver at the study site.

排除标准

  • Use of antibiotics in the preceding two weeks before recruitment into the study.
  • Allergy to metronidazole or clindamycin
  • Previous history of preterm birth
  • Previous and present history of preterm premature rupture of membrane (SPROM)
  • Patient on cerclage.
  • Chronic medical disorders that can predispose to preterm birth such as diabetes mellitus, lentiviral infection and hypertensive disorders in pregnancy.
  • Multiple pregnancy

研究者

发起方
self funded

相似试验